Reports for SANDOZ CANADA INCORPORATED

Company Name
SANDOZ CANADA INCORPORATED

Shortage reports

Actual shortage:

35 (1%)

Anticipated shortage:

9 (0%)

Avoided shortage:

19 (1%)

Resolved:

2320 (97%)

2383

Discontinuation Reports

To be discontinued:

3 (2%)

Discontinued:

131 (96%)

Reversed:

2 (1%)

136

466 (18%)

3 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
KETAMINE HYDROCHLORIDE INJECTION USP 50MG SOLUTION Resolved 2025-08-21 2025-09-13 265725
KETOROLAC TROMETHAMINE INJECTION USP 30MG LIQUID Resolved 2022-07-06 2023-03-21 164211
KETOROLAC TROMETHAMINE INJECTION USP 30MG LIQUID Resolved 2022-06-22 2022-06-30 163226
KETOROLAC TROMETHAMINE INJECTION USP 30MG LIQUID Resolved 2019-01-22 2019-03-13 73188
KETOROLAC TROMETHAMINE INJECTION USP 30MG SOLUTION LIQUID Resolved 2025-07-07 2025-08-05 261967
KETOROLAC TROMETHAMINE INJECTION USP 30MG LIQUID Resolved 2020-06-08 2021-03-29 116929
KETOROLAC TROMETHAMINE INJECTION USP 30MG LIQUID Resolved 2017-03-14 2017-04-12 2621
L-ARGININE HYDROCHLORIDE INJECTION 250MG LIQUID Resolved 2023-03-28 2024-02-07 188188
L-ARGININE HYDROCHLORIDE INJECTION 250MG LIQUID Resolved 2021-04-28 2022-05-06 138151
L-ARGININE HYDROCHLORIDE INJECTION 250MG LIQUID Resolved 2022-09-02 2023-01-19 168545
LABETALOL HYDROCHLORIDE INJECTION USP 5MG LIQUID Resolved 2019-03-05 2019-06-28 77737
LABETALOL HYDROCHLORIDE INJECTION USP 5MG SOLUTION LIQUID Resolved 2025-03-03 2025-04-01 251573
LABETALOL HYDROCHLORIDE INJECTION USP 5MG LIQUID Resolved 2018-11-26 2018-12-05 67605
LABETALOL HYDROCHLORIDE INJECTION USP 5MG LIQUID Resolved 2021-12-02 2021-12-30 150323
LABETALOL HYDROCHLORIDE INJECTION USP 5MG SOLUTION LIQUID Resolved 2025-01-13 2025-02-11 247608
LABETALOL HYDROCHLORIDE INJECTION USP 5MG LIQUID Resolved 2017-10-27 2017-11-19 27239
LABETALOL HYDROCHLORIDE INJECTION USP 5MG LIQUID Resolved 2022-02-02 2022-03-11 154106
LABETALOL HYDROCHLORIDE INJECTION USP 5MG LIQUID Resolved 2022-03-14 2022-04-20 156669
LABETALOL HYDROCHLORIDE INJECTION USP 5MG SOLUTION LIQUID Resolved 2025-06-02 2025-07-01 259061
LABETALOL HYDROCHLORIDE INJECTION USP 5MG LIQUID Resolved 2022-06-09 2022-10-20 162363
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ANGIOMAX 250MG POWDER FOR SOLUTION Discontinued 2026-03-16 2026-03-19 280590
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BORTEZOMIB FOR INJECTION SDZ 3.5MG POWDER FOR SOLUTION Discontinued 2026-03-16 2026-03-19 280595
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467
KETOROLAC TROMETHAMINE INJECTION USP 30MG SOLUTION LIQUID Discontinued 2025-08-04 2025-08-05 264341
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265

Showing 1 to 20 of 136